Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
申请人:Sankyo Company Limited
公开号:EP0484094A2
公开(公告)日:1992-05-06
Compounds of formula (I) :
(in which : R1 is a hydrogen atom, an unsubstituted alkyl group, an aryl-substituted alkyl group or a heterocyclic-substituted alkyl group ; R2 is an aryl-substituted alkyl group, a heterocyclic-substituted alkyl group or a diarylamino group ; R3 is a hydrogen atom, an unsubstituted alkyl group, an aryl-substituted alkyl group or an alkenyl group having from 3 to 6 carbon atoms ; and each of the bonds represented by α-β and y-8 is a carbon-carbon single bond or a carbon-carbon double bond ;) and pharmaceutically acceptable salts and esters thereof are useful for the treatment and prophylaxis of prostatic hypertrophy. We also provide processes for their preparation.
式(I)化合物
(其中:R1 是氢原子、未取代的烷基、芳基取代的烷基或杂环取代的烷基; R2 是芳基取代的烷基、杂环取代的烷基或二芳基氨基; R3 是氢原子、未取代的烷基、芳基取代的烷基或具有 3 至 6 个碳原子的烯基;α-β和y-8所代表的键中的每一个都是碳-碳单键或碳-碳双键;)及其药学上可接受的盐和酯可用于治疗和预防前列腺肥大。我们还提供了其制备工艺。